Eli Gabayan
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
-
- Protein Degradation and Inhibitors 7
- Ubiquitin and proteasome pathways 2
-
- Multiple Myeloma Research and Treatments 7
- Co-authors
- David Irwin (5 shared papers)Elber S. Camacho (5 shared papers)David P. Schenkein (5 shared papers)Jeffrey L. Wolf (5 shared papers)Marti McKinley (5 shared papers)Jose Lutzky (5 shared papers)Sundar Jagannath (5 shared papers)John Crowley (3 shared papers)
- Journals
- Blood (3 papers)Journal of Clinical Oncology (2 papers)British Journal of Haematology (1 paper)Clinical Lymphoma Myeloma & Leukemia (1 paper)
- Partner nations
- United StatesSweden
In The Last Decade
Eli Gabayan
6 papers receiving 345 citations
Peers
Comparison fields: 5 of 35
- Hematology 298
- Oncology 157
- Molecular Biology 238
- Genetics 18
- Pathology and Forensic Medicine 8
Countries citing papers authored by Eli Gabayan
This map shows the geographic impact of Eli Gabayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Gabayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Gabayan more than expected).
Fields of papers citing papers by Eli Gabayan
This network shows the impact of papers produced by Eli Gabayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Gabayan. The network helps show where Eli Gabayan may publish in the future.
Co-authors
The 15 scholars most cited alongside Eli Gabayan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 316 | |
| 2 | 2004 | 20 | |
| 3 | 2005 | 14 | |
| 4 | 2024 | 5 | |
| 5 | 2004 | 5 | |
| 6 | 2004 | 3 | |
| 7 | 2025 | 0 |
About Eli Gabayan
Eli Gabayan is a scholar working on Molecular Biology, Hematology, Genetics, Pathology and Forensic Medicine and Neurology, having authored 7 papers that have together received 363 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (7 papers), Cancer Mechanisms and Therapy (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Ubiquitin and proteasome pathways (2 papers) and Peripheral Neuropathies and Disorders (1 paper). The work is most often cited by research in Hematology (298 citations), Oncology (157 citations), Molecular Biology (238 citations), Genetics (18 citations) and Pathology and Forensic Medicine (8 citations). Eli Gabayan has collaborated with scholars based in United States and Sweden. Frequent co-authors include David Irwin, Elber S. Camacho, David P. Schenkein, Jeffrey L. Wolf, Marti McKinley, Jose Lutzky, Sundar Jagannath, John Crowley, Amitabha Mazumder and Brian G.M. Durie. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology and Clinical Lymphoma Myeloma & Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.